Press release
Complex Regional Pain Syndrome (CRPS) Market Expands as Neuropathic Pain Therapies, Spinal Cord Stimulation, and Early Diagnosis Improve Patient Outcomes
Complex Regional Pain Syndrome (CRPS) Market
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72088
Keyword Definition
Complex Regional Pain Syndrome (CRPS) is a chronic, severe pain condition typically affecting a limb after trauma, surgery, fracture, or nerve injury. It is divided into:
• CRPS Type I: Occurs without confirmed nerve lesion
• CRPS Type II: Associated with documented nerve injury
CRPS symptoms include:
• Burning or throbbing pain
• Swelling and hypersensitivity
• Changes in skin temperature or color
• Motor dysfunction, stiffness, tremors
• Psychological distress and functional disability
Management is multidisciplinary and time-sensitive, combining:
• Pharmacologic therapy (gabapentin, pregabalin, TCAs, SNRIs, corticosteroids, bisphosphonates, topical agents)
• Interventional pain procedures (sympathetic blocks, ketamine infusions)
• Spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation
• Physical therapy and graded motor imagery
• Psychological support
Market Size, CAGR and Outlook
Based on consolidated analyses of global neuropathic pain, CRPS, and neuromodulation markets:
• The CRPS treatment market is valued at around USD 600-700 million in 2024.
• It is projected to reach USD 1.0-1.2 billion by 2034,
• Representing a CAGR of approximately 6-7% over the forecast period.
When including adjacent markets (neuropathic pain drugs + neuromodulation devices):
• Total addressable value exceeds USD 5-7 billion,
• Supported by rising adoption of SCS and DRG stimulation systems.
Key growth drivers include:
• Increasing incidence of trauma-associated and post-surgical CRPS
• Greater clinical emphasis on early diagnosis and aggressive management
• Growing demand for SCS and DRG therapies for refractory cases
• Significant patient and clinician interest in non-opioid pain solutions
Key Players
The CRPS market includes pharmaceutical companies, neuromodulation device manufacturers, and providers of interventional pain therapies.
Neuromodulation & Device Leaders
• Abbott (DRG stimulation systems; ProclaimTM SCS)
• Medtronic (IntellisTM, VantaTM, and earlier SCS systems)
• Boston Scientific (WaveWriter AlphaTM, Precision MontageTM SCS)
• Nevro (HFXTM 10 kHz SCS technology)
Pharmaceutical Companies
• Firms developing and supplying gabapentinoids, antidepressants (SNRIs, TCAs), bisphosphonates, corticosteroids, topical analgesics, and emerging neuropathic pain therapies
• Specialty companies offering ketamine-related interventions or NMDA-modulating pain therapeutics
• Biotechs working on novel sodium-channel modulators (e.g., NaV1.7), based agents, or monoclonal antibodies for neuropathic pain
Pain Management Service Providers
• Interventional pain clinics
• Rehabilitation and occupational therapy centers
• Multidisciplinary pain institutes integrating physio, psych, and nerve blocks
Market Segmentation and Growth Insights
By Treatment Modality
Pharmacologic Therapy (Largest Volume Segment)
• Includes gabapentin, pregabalin, duloxetine, amitriptyline, NSAIDs, corticosteroids, bisphosphonates, ketamine (infusion or topical), and lidocaine patches.
• Represents the majority of early-stage CRPS management.
Interventional Pain Procedures (Growing Segment)
• Sympathetic nerve blocks (stellate ganglion, lumbar sympathetic)
• Ketamine infusions
• Regional anesthesia/nerve blocks for severe flare-ups
• Increasing adoption in specialized centers.
Neuromodulation (High-Value Fastest Growing Segment)
• Spinal Cord Stimulation (SCS)
• Dorsal Root Ganglion (DRG) Stimulation - particularly impactful for focal limb CRPS
• DRG technology's targeted stimulation has become a breakthrough for refractory CRPS.
Rehabilitation & Behavioral Therapy
• Graded motor imagery, mirror therapy, pain education
• Functional restoration programs
• Growing inclusion in comprehensive CRPS treatment models.
By CRPS Type
• CRPS Type I (Reflex Sympathetic Dystrophy) - Majority of global cases; large treatment population.
• CRPS Type II (Causalgia) - Smaller but high-complexity segment; often requires more intensive interventions.
By End User
• Pain management centers
• Neurology and neurosurgery centers
• Outpatient interventional pain clinics
• Rehabilitation hospitals
• Multidisciplinary chronic pain programs
Regional Insights
North America
• Largest market, propelled by early adoption of SCS/DRG, high awareness, and strong reimbursement.
• Extensive presence of advanced pain clinics and neuromodulation manufacturers.
Europe
• Significant market driven by structured pain-management pathways, growing DRG adoption, and high standards for rehabilitation.
Asia-Pacific
• Fastest-growing region due to rising trauma incidence, increasing availability of pain specialists, and expanding reimbursement for neuromodulation in select countries.
Latin America & Middle East/Africa
• Emerging markets with growing access to interventional pain treatments, but limited by specialist availability and cost barriers.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72088/complex-regional-pain-syndrome-crps-market
Key Market Drivers
• Rising post-fracture and post-surgical CRPS cases, particularly in orthopedic populations
• Increasing use of SCS and DRG stimulation, with strong clinical evidence for CRPS pain relief
• Expanding availability of ketamine infusions, sympathetic blocks, and non-opioid pain-management protocols
• Growing number of multidisciplinary pain centers
• Technological innovation in neuromodulation (higher precision, closed-loop systems, longer battery life, improved targeting)
• High unmet need-CRPS remains difficult to treat, and many patients become refractory to standard medications
• Increasing global push for non-opioid pain therapies due to opioid stewardship policies
Conclusion
The Complex Regional Pain Syndrome (CRPS) Market is evolving from traditional neuropathic pain management to a technology-forward, interventional, and multidisciplinary care model. With:
• Current market value of USD 600-700 million (core CRPS segment),
• Expected growth to USD 1.0-1.2 billion by 2034,
• And a strong CAGR of 6-7%,
CRPS presents meaningful commercial potential across drug, device, and service categories.
Companies and providers that focus on:
• Advanced SCS/DRG neuromodulation,
• Non-opioid pharmacologic innovation,
• Integrated rehab and pain-management pathways,
• And accessible interventional care models
will be best positioned to lead the CRPS market through the next decade.
This report is also available in the following languages : Japanese (複合性局所疼痛症候群市場), Korean (복합성 국소 통증 증후군 시장), Chinese (复杂区域疼痛综合征市场), French (marché du syndrome douloureux régional complexe), German (Markt für komplexes regionales Schmerzsyndrom), and Italian (Mercato della sindrome dolorosa regionale complessa), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72088
Our More Reports:
West Syndrome Market
https://exactitudeconsultancy.com/reports/72082/west-syndrome-market
Complex Regional Pain Syndrome Market
https://exactitudeconsultancy.com/reports/72084/complex-regional-pain-syndrome-market
Dravet Syndrome (DS) Market
https://exactitudeconsultancy.com/reports/72087/dravet-syndrome-ds-market
Complex Regional Pain Syndrome (CRPS) Market
https://exactitudeconsultancy.com/reports/72088/complex-regional-pain-syndrome-crps-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Complex Regional Pain Syndrome (CRPS) Market Expands as Neuropathic Pain Therapies, Spinal Cord Stimulation, and Early Diagnosis Improve Patient Outcomes here
News-ID: 4302773 • Views: …
More Releases from Exactitude Consultancy
Traumatic Brain Injury (TBI) Market Accelerates as Advanced Monitoring, Neurocri …
The Traumatic Brain Injury (TBI) Market is transitioning from basic acute stabilization to a full continuum-of-care model that spans pre-hospital triage, neurocritical care, advanced monitoring, and long-term rehabilitation. With tens of millions of new TBI cases globally each year and high lifetime disability risk, demand is rising for better diagnostics, monitoring devices, neuroprotective drugs, and rehab technologies that can improve survival and functional outcomes.
Download Full PDF Sample Copy of Market…
West Syndrome Market Rises as Early Diagnosis, Hormonal Therapy, and Novel AEDs …
The West Syndrome Market is moving from under-recognized niche to a focused rare-epilepsy segment with meaningful commercial potential. As clinicians and parents become more aware of infantile spasms and hypsarrhythmia on EEG, demand is rising for rapid initiation of hormonal therapies, vigabatrin, and supportive neurodevelopmental care. Over the next decade, broader newborn and infant screening, better referral pathways, and targeted drug development are expected to reshape the landscape for this…
Treatment-Resistant Depression (TRD) Market Expands as Novel Mechanisms, Rapid-A …
The Treatment-Resistant Depression (TRD) Market is entering one of the most dynamic phases in the history of psychiatry. Traditional monoaminergic antidepressants leave a large share of patients with partial or no response. This unmet need is fueling demand for rapid-acting drugs, NMDA-targeting agents, neuromodulation devices, digital therapeutics, and more personalized treatment pathways. Over the next decade, TRD will be a core focus area for pharma, med-tech, and digital health companies…
Transient Ischemic Attack (TIA) Market Grows as Early Diagnosis, AI-Enabled Stro …
The Transient Ischemic Attack (TIA) Market is transforming as healthcare systems shift focus from delayed stroke management to rapid TIA triage and prevention. With TIAs serving as a critical early warning sign for major strokes, demand for advanced diagnostics, AI-assisted imaging, emergency care pathways, and secondary-prevention drugs is increasing worldwide. The next decade will be defined by precision risk assessment, accelerated imaging, and a global push to reduce preventable strokes.
Download…
More Releases for CRPS
Complex Regional Pain Syndrome (CRPS) Market to Reach USD 1.9 Billion by 2034
Pune, India - November 2025 - Exactitude Consultancy announces that the Global Complex Regional Pain Syndrome (CRPS) Market is set for robust expansion over the next decade, driven by the evolution of neurostimulation technologies, improved clinical diagnostics, and personalized rehabilitation programs. As healthcare providers prioritize multidisciplinary pain management, CRPS treatment strategies are shifting toward integrated care models that combine pharmacotherapy, physical therapy, and neuromodulation.
Download Full PDF Sample Copy of Market…
Complex Regional Pain Syndrome (CRPS) Market New Product Development & Latest Tr …
Introduction
Complex Regional Pain Syndrome (CRPS) is a chronic, rare neurological disorder that typically develops after an injury, fracture, or surgery. It is characterized by disproportionate pain, changes in skin color and temperature, swelling, and limited mobility. Although rare, CRPS has a profound impact on patients' quality of life and poses challenges for healthcare providers due to its complex diagnosis and management.
Growing awareness of chronic pain syndromes, increased demand for effective…
Inside the Cycle of CRPS: Stella Artuso's Story of Resilience
Stella Artuso's condition seemed to be incurable until her parents found the Arkansas-based Spero Clinic. This is a one-of-a-kind facility specializing in treating conditions such as Complex Regional Pain Syndrome.
Image: https://www.globalnewslines.com/uploads/2025/04/b46865964236fed3bbd45c5bc89f50e1.jpg
"I always felt like I was present in moments, but I was separated by a barrier of pain. I couldn't smile without faking." - Stella Arturo.
Imagine being 12 years old, enjoying life, sports, running, and having a great time. Then,…
A New Chapter: The Spero Clinic Helps CRPS Patient Lou Reclaim Her Life
CRPS is causing constant, debilitating pain for people around the world. Here's what The Spero Clinic is doing to save lives from this dreadful disease.
Image: https://www.globalnewslines.com/uploads/2025/02/a3269782b20b4832d25263680ae9bac8.jpg
"I had absolute plans to kill myself because I just thought this is not a life that I want."
Statements such as these sound alarming, but the truth is that many patients suffering from Complex Regional Pain Syndrome (CRPS) end up feeling this way. Why?
Because CRPS,…
Paula's Journey: CRPS Survivor Finds Hope and Healing at the Spero Clinic
Paula, a survivor of Complex Regional Pain Syndrome (CRPS), shares her transformative journey toward healing at The Spero Clinic. CRPS is a chronic pain condition affecting millions, often triggered by an injury or medical event, causing severe pain, muscle spasms, and mobility issues.
Image: https://www.globalnewslines.com/uploads/2025/02/2ce8be74be632434741ecf707cfafe58.jpg
CRPS, or Complex Regional Pain Syndrome, is a chronic pain condition that affects between 5 and 8 million people around the world. CRPS [https://www.thesperoclinic.com/conditions/complex-regional-pain-syndrome/] is often triggered…
Complex Regional Pain Syndrome (CRPS) Market to expand at a 2.2% value CAGR by 2 …
The global complex regional pain syndrome (CRPS) market is expected to be worth US$ 101.9 million in 2022, rising to US$ 126.7 million by 2032. During the forecast period of 2022 to 2032, the market is expected to grow at a 2.2% CAGR.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1708
Complex Regional Pain Syndrome (CRPS) is a chronic condition that causes severe pain in legs, arms, feet, and hands or may involve the entire body. CRPS…
